Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Iradimed Cp (IRMD)

16.075 0.075 (0.47%)

04-25 15:59

Open:

16

Pre. Close:

16

High:

16.2

Low:

15.85

Volume:

6,746

Market Cap:

170M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

16.019 - 16.103

16.103 - 16.175

Low:

15.647 - 15.744

15.744 - 15.827

Close:

15.741 - 15.905

15.905 - 16.045

Technical analysis  (as of: 2018-04-25 4:28:17 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 19.21     One year: 22.44

Support:

Support1: 14.78    Support2: 13.75

Resistance:

Resistance1: 16.45    Resistance2: 19.21

Pivot:

15.47

Moving Averages:

MA(5): 15.79     MA(20): 15.18

MA(100): 14.36     MA(250): 11.71

MACD:

MACD(12,26): 0.49     Signal(12,26,9): 0.46

%K %D:

%K(14,3): 77.24     %D(3): 72.22

RSI:

RSI(14): 63.82

52-Week:

High: 16.45  Low: 8  Change(%): 79.7

Average Vol(K):

3-Month: 1029  10-Days 1132

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
IRMD has closed below upper band by 32.8%. Bollinger Bands are 32.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-02-06T17:20:05-05:00
IRADIMED's (IRMD) CEO Roger Susi on Q4 2017 Results - Earnings Call Transcript

2018-02-06T07:06:19-05:00
iRadimed beats by $0.04, beats on revenue

2018-01-22T08:23:11-05:00
IRADIMED announces Q1 and FY 2018 financial guidance

2017-11-28T07:43:47-05:00
Your Daily Pharma Scoop: Synergy In 2018, Repatha Action Date, Alkermes Signs Deal

2017-10-30T15:15:42-04:00
IRADIMED's (IRMD) CEO Roger Susi on Q3 2017 Results - Earnings Call Transcript

2017-10-30T07:19:35-04:00
iRadimed Q3 revenues off 26%; updates guidance

2017-10-30T07:04:31-04:00
iRadimed beats by $0.04, beats on revenue

2017-10-26T12:52:52-04:00
Midday Gainers / Losers

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Equipment

Shares Out. (M)

10.60

Shares Float (M)

10.20

% Held by Insiders

3.80

% Held by Institutions

14.70

Shares Short (K)

858

Shares Short Prior Month (K)

787

Stock Financials

EPS

0.090

EPS Est. Current Year

0.130

EPS Est. Next Year

0.230

EPS Est. Next Quarter

0.040

Forward EPS

0.630

Book Value (p.s.)

5.090

PEG Ratio

2.55

Profit Margin

4.09

Operating Margin

5.57

Return on Assets (ttm)

1.3

Return on Equity (ttm)

1.5

Qtrly Rev. Growth

11.9

Gross Profit (p.s.)

1.651

Sales Per Share

EBITDA (p.s.)

0.245

Qtrly Earnings Growth

-83.90

Operating Cash Flow (M)

3.42

Levered Free Cash Flow (M)

3.57

atoplab.com

Valuation

P/E

176.67

P/E Growth Ratio

-0.01

P/BV

3.12

P/S

77668200.00

P/CF

49.30

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.